Cryoablation of Lung Metastases: Review of Recent Literature and Ablation Technique

Abstract

This article reviews the current indications for image-guided thermal ablation of pulmonary metastatic disease. It also summarizes data regarding the efficacy and complications of lung cryoablation and present techniques for performing lung cryoablation as informed by the recent literature.

Keywords

ablation - cyroablation - lung metastasis

• References

• 1 Boyer MJ, Ricardi U, Ball D, Salama JK. Ablative approaches for pulmonary metastases. Thorac Surg Clin 2016; 26 (01) 19-34
• 2 Pastorino U, Buyse M, Friedel G. , et al; International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113 (01) 37-49
• 3 Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995; 13 (01) 8-10
• 4 Ning MS, Gomez DR, Heymach JV, Swisher SG. Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease. Transl Lung Cancer Res 2019; 8 (01) 97-106
• 5 de Baère T, Aupérin A, Deschamps F. , et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015; 26 (05) 987-991
• 6 Gillams A, Khan Z, Osborn P, Lees W. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol 2013; 36 (03) 724-730
• 7 Petre EN, Jia X, Thornton RH. , et al. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clin Colorectal Cancer 2013; 12 (01) 37-44
• 8 Ni Y, Liu B, Ye X. , et al. Local thermal ablation with continuous EGFR tyrosine kinase inhibitors for EGFR-mutant non-small cell lung cancers that developed extra-central nervous system (CNS) oligoprogressive disease. Cardiovasc Intervent Radiol 2019; 42 (05) 693-699
• 9 Qiu B, Liang Y, Li Q. , et al. Local therapy for oligoprogressive disease in patients with advanced stage non-small-cell lung cancer harboring epidermal growth factor receptor mutation. Clin Lung Cancer 2017; 18 (06) e369-e373
• 10 de Baere T, Tselikas L, Yevich S. , et al. The role of image-guided therapy in the management of colorectal cancer metastatic disease. Eur J Cancer 2017; 75: 231-242
• 11 Abtin F, De Baere T, Dupuy DE. , et al. Updates on current role and practice of lung ablation. J Thorac Imaging 2019; 34 (04) 266-277
• 12 Lee KS, Erinjeri JP. Decision making in interventional oncology: ablative options in the lung. Semin Intervent Radiol 2017; 34 (02) 176-181
• 13 de Baere T, Tselikas L, Woodrum D. , et al. Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: the ECLIPSE trial--interim analysis at 1 year. J Thorac Oncol 2015; 10 (10) 1468-1474
• 14 Lyons GR, Askin G, Pua BB. Clinical outcomes after pulmonary cryoablation with the use of a triple freeze protocol. J Vasc Interv Radiol 2018; 29 (05) 714-721
• 15 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?. Radiographics 2014; 34 (05) 1344-1362
• 16 Atwell TD, Carter RE, Schmit GD. , et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol 2012; 23 (01) 48-54
• 17 Thacker PG, Callstrom MR, Curry TB. , et al. Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients' immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2011; 197 (02) 510-515
• 18 Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations. Radiology 2005; 237 (01) 366-370
• 19 Colak E, Tatlı S, Shyn PB, Tuncalı K, Silverman SG. CT-guided percutaneous cryoablation of central lung tumors. Diagn Interv Radiol 2014; 20 (04) 316-322
• 20 Lyons GR, Winokur RS, Pua BB. Pulmonary Cryoablation Zones: More Aggressive Ablation Is Warranted In Vivo. AJR Am J Roentgenol 2019; 212 (01) 195-200
• 21 Yashiro H, Nakatsuka S, Inoue M. , et al. Factors affecting local progression after percutaneous cryoablation of lung tumors. J Vasc Interv Radiol 2013; 24 (06) 813-821
• 22 Inoue M, Nakatsuka S, Yashiro H. , et al. Percutaneous cryoablation of lung tumors: feasibility and safety. J Vasc Interv Radiol 2012; 23 (03) 295-302 , quiz 305
• 23 Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 2005; 235 (01) 289-298
• 24 McDevitt JL, Mouli SK, Nemcek AA, Lewandowski RJ, Salem R, Sato KT. Percutaneous cryoablation for the treatment of primary and metastatic lung tumors: identification of risk factors for recurrence and major complications. J Vasc Interv Radiol 2016; 27 (09) 1371-1379
• 25 Borghol S, Alberti N, Frulio N. , et al. Pulmonary artery pseudoaneurysm after radiofrequency ablation: report of two cases. Int J Hyperthermia 2015; 31 (01) 1-4
• 26 Garnon J, Cazzato RL, Caudrelier J. , et al. Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol 2019; 42 (03) 344-357
• 27 Yamauchi Y, Izumi Y, Hashimoto K. , et al. Needle-tract seeding after percutaneous cryoablation for lung metastasis of colorectal cancer. Ann Thorac Surg 2011; 92 (04) e69-e71
• 28 Chaudhuri AA, Binkley MS, Aggarwal S. , et al. Severe chest wall toxicity from cryoablation in the setting of prior stereotactic ablative radiotherapy. Cureus 2016; 8 (02) e477
• 29 Dupuy DE, Fernando HC, Hillman S. , et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer 2015; 121 (19) 3491-3498
• 30 Palussière J, Chomy F, Savina M. , et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg 2018; 13 (01) 91
• 31 Timmerman R, Paulus R, Galvin J. , et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303 (11) 1070-1076
• 32 Elliott BA, Curry TB, Atwell TD, Brown MJ, Rose SH. Lung isolation, one-lung ventilation, and continuous positive airway pressure with air for radiofrequency ablation of neoplastic pulmonary lesions. Anesth Analg 2006; 103 (02) 463-464 , table of contents
• 33 Pan PJ, Bansal AK, Genshaft SJ, Kim GH, Suh RD, Abtin F. Comparison of double-freeze versus modified triple-freeze pulmonary cryoablation and hemorrhage volume using different probe sizes in an in vivo porcine lung. J Vasc Interv Radiol 2018; 29 (05) 722-728
• 34 Hinshaw JL, Littrup PJ, Durick N. , et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33 (06) 1180-1185
• 35 Powell DK, Baum S. Bronchopleural fistula treated with n-butyl cyanoacrylate glue after ablation. J Vasc Interv Radiol 2018; 29 (12) 1692-1693
• 36 Zheng A, Yang X, Ye X. , et al. Bronchopleural fistula after lung ablation: Experience in two cases and literature review. Indian J Cancer 2015; 52 (Suppl. 02) e41-e46
• 37 York JA. Treating bronchopleural fistulae percutaneously with N-butyl cyanoacrylate glue. J Vasc Interv Radiol 2013; 24 (10) 1581-1583
• 38 Hiraki T, Gobara H, Fujiwara H. , et al. Lung cancer ablation: complications. Semin Intervent Radiol 2013; 30 (02) 169-175
• 39 Alexander ES, Healey TT, Martin DW, Dupuy DE. Use of endobronchial valves for the treatment of bronchopleural fistulas after thermal ablation of lung neoplasms. J Vasc Interv Radiol 2012; 23 (09) 1236-1240
• 40 Thornton RH, Solomon SB, Dupuy DE, Bains MS. Phrenic nerve injury resulting from percutaneous ablation of lung malignancy. AJR Am J Roentgenol 2008; 191 (02) 565-568
• 41 Ito N, Nakatsuka S, Inoue M. , et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol 2012; 23 (08) 1043-1052
• 42 Kawamura M, Izumi Y, Tsukada N. , et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 2006; 131 (05) 1007-1013
• 43 Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD. Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics 2012; 32 (04) 947-969
• 44 Higuchi M, Suzuki H, Gotoh M. Role of PET/computed tomography in radiofrequency ablation for malignant pulmonary tumors. PET Clin 2016; 11 (01) 47-55
• 45 LoGiurato B, Matthews R, Safaie E. , et al. 18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer. Nucl Med Commun 2015; 36 (09) 908-913
• 46 Romanato J, Menezes MR, Santos AO, Bezerra ROF, Lima MCL, Etchebehere E. ¹⁸F-FDG PET/CT performed immediately after percutaneous ablation to evaluate outcomes of the procedure: preliminary results. Radiol Bras 2019; 52 (01) 24-32